GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AdAlta Ltd (ASX:1AD) » Definitions » Price-to-Free-Cash-Flow

AdAlta (ASX:1AD) Price-to-Free-Cash-Flow : N/A (As of Dec. 13, 2024)


View and export this data going back to 2016. Start your Free Trial

What is AdAlta Price-to-Free-Cash-Flow?

As of today (2024-12-13), AdAlta's share price is A$0.017. AdAlta's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.01. Hence, AdAlta's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for AdAlta's Price-to-Free-Cash-Flow or its related term are showing as below:

ASX:1AD's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 35.545
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

AdAlta's Free Cash Flow per Share for the six months ended in Dec. 2023 was A$-0.01. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was A$-0.01.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 23.00% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 20.80% per year.

During the past 8 years, AdAlta's highest 3-Year average Free Cash Flow per Share Growth Rate was 32.60% per year. The lowest was 3.50% per year. And the median was 20.40% per year.


AdAlta Price-to-Free-Cash-Flow Historical Data

The historical data trend for AdAlta's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AdAlta Price-to-Free-Cash-Flow Chart

AdAlta Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial - - - - -

AdAlta Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of AdAlta's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, AdAlta's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AdAlta's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AdAlta's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where AdAlta's Price-to-Free-Cash-Flow falls into.



AdAlta Price-to-Free-Cash-Flow Calculation

AdAlta's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.017/-0.011
=N/A

AdAlta's Share Price of today is A$0.017.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. AdAlta's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

AdAlta  (ASX:1AD) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


AdAlta Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of AdAlta's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


AdAlta Business Description

Industry
Traded in Other Exchanges
N/A
Address
Science Drive, La Trobe Institute for Molecular Science, Room 204, LIMS2, La Trobe University, Bundoora, VIC, AUS, 3086
AdAlta Ltd is engaged in drug discovery and developing protein therapeutics, known as i-bodies, for treating a wide range of human diseases. The principal business of AdAlta is the discovery and development of next-generation protein and cell-based therapeutics. The i-body candidate, AD-214, is being developed for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases, for which current therapies are sub-optimal. Its pipeline includes Fibrosis and CAR-T cancer therapeutics.

AdAlta Headlines

No Headlines